Collaboration Agreements in the Unassigned Industry
269 Contracts & Agreements
- ABGENIX INC (1 contract)
- ACELYRIN, Inc. (1)
- Acologix, Inc. (4)
- ACUSPHERE INC (3)
- ADOLOR CORP (7)
- ADVISORY BOARD CO (1)
- AFFYMAX INC (1)
- ALKERMES INC (2)
- ALLERGAN INC (2)
- Amarantus Bioscience Holdings, Inc. (1)
- AMBIT BIOSCIENCES CORP (6)
- Ariosa Diagnostics, Inc. (5)
- ArriVent Biopharma, Inc. (3)
- ATHEROGENICS INC (1)
- BG Medicine, Inc. (4)
- Biolex, Inc. (1)
- BioNeutral Group, Inc (1)
- BioTrove, Inc. (3)
- CALIPER LIFE SCIENCES INC (1)
- CEB Inc. (1)
- CELL GENESYS INC (1)
- CEPHALON INC (1)
- Ceres, Inc. (2)
- CG Oncology, Inc. (2)
- CombiMatrix Corp (1)
- Corium International, Inc. (2)
- CURAGEN CORP (3)
- CYPRESS BIOSCIENCE INC (1)
- Dance Biopharm, Inc. (3)
- DELTAGEN INC (1)
- Deyu Agriculture Corp. (1)
- DGI RESOLUTION INC (1)
- DYAX CORP (3)
- Ealixir, Inc. (2)
- ECOTALITY, INC. (3)
- Elevai Labs Inc. (1)
- ENDOCYTE INC (1)
- EPIRUS Biopharmaceuticals, Inc. (4)
- Espre Solutions Inc (1)
- Foundation Medicine, Inc. (13)
- FOXHOLLOW TECHNOLOGIES, INC. (1)
- GENENTECH INC (1)
- GENVEC INC (3)
- GENZYME CORP (1)
- Global Secure Corp. (11)
- GLOBEIMMUNE INC (9)
- HypGen Inc (1)
- IIOT-OXYS, Inc. (1)
- Independence Resources PLC (1)
- INFORMATICA CORP (2)
- INFORMEDIX HOLDINGS INC (1)
- INHIBITEX, INC. (3)
- Intellect Neurosciences, Inc. (1)
- INTELLON CORP (3)
- INTERMUNE INC (1)
- International Spirits & Beverage Group, Inc. (1)
- INYX INC (1)
- KINEMED INC (2)
- Kite Pharma, Inc. (4)
- Klaviyo, Inc. (1)
- KYTHERA BIOPHARMACEUTICALS INC (3)
- LIPOSCIENCE INC (3)
- Loxo Oncology, Inc. (4)
- Maison Solutions Inc. (1)
- MARTEK BIOSCIENCES CORP (1)
- MAXYGEN INC (1)
- MEDAREX INC (1)
- MEDICIS PHARMACEUTICAL CORP (1)
- MEDIVATION, INC. (4)
- MICROFLUIDICS INTERNATIONAL CORP (2)
- MICROMET, INC. (2)
- Mobileye Global Inc. (2)
- MON SPACE NET INC. (1)
- Monogram Biosciences, Inc. (2)
- MYOGEN INC (4)
- NAAC Holdco, Inc. (1)
- Nano Labs Corp. (1)
- NANOGEN INC (3)
- Nascent Biotech Inc. (1)
- NEONC TECHNOLOGIES HOLDINGS, INC. (1)
- Neuraxis, INC (1)
- NEUROGEN CORP (1)
- NEUROLOGIX INC (2)
- Nexvet Biopharma plc (1)
- NOVELL INC (4)
- OSL HOLDINGS, INC. (2)
- PAULSON CAPITAL (DELAWARE) CORP. (1)
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC (1)
- PHARMACOPEIA INC (2)
- PHARMACYCLICS INC (2)
- Pharmasset Inc (1)
- PHINIA INC. (1)
- Phoenix Plus Corp. (2)
- POZEN INC (7)
- Prime Medicine, Inc. (1)
- PUBLIC MEDIA WORKS INC (2)
- Raptor Pharmaceutical Corp (1)
- RayzeBio, Inc. (2)
- Receptos, Inc. (7)
- Redpoint Bio CORP (1)
- RENOVIS INC (2)
- RESPONSE BIOMEDICAL CORP (2)
- Rokk3r Inc. (1)
- SEAHAWK DRILLING, INC. (1)
- SEQUENOM INC (1)
- Shire plc (1)
- Signing Day Sports, Inc. (1)
- STRESSGEN BIOTECHNOLOGIES CORP (1)
- SUN MICROSYSTEMS, INC. (1)
- SURF AIR MOBILITY INC. (3)
- TENGION INC (1)
- TerraVia Holdings, Inc. (1)
- TESARO, Inc. (7)
- Tesspay Inc. (1)
- TULARIK INC (1)
- Turnstone Biologics Corp. (1)
- UAS Drone Corp. (1)
- UNIVERSAL BIOSENSORS INC (3)
- VERENIUM CORP (4)
- VIACELL INC (4)
- VIRAGEN INC (1)
- VIROPHARMA INC (1)
- Zymeworks Delaware Inc. (3)
- Addendum to Collaboration Agreement dated December 27, 2021, by and between Enea Angelo Trevisan and Ealixir Hispania, S.L.U, dated April 28, 2023 (Ealixir, Inc., Filed With SEC on April 3, 2024)
- Collaboration Agreement, by and between Enea Angelo Trevisan and Ealixir Hispania, S.L.U, dated December 27, 2021 (Ealixir, Inc., Filed With SEC on April 3, 2024)
- Collaboration Agreement by and between the Company and Integrated Path Communications LLC dated as of June 15, 2023 (Tesspay Inc., Filed With SEC on January 26, 2024)
- Clinical Collaboration Agreement, by and between the Registrant and Beijing InnoCare Pharma Tech Co., Ltd., dated June 23, 2023 (ArriVent Biopharma, Inc., Filed With SEC on January 5, 2024)
- Research Collaboration Agreement, dated December 21, 2021, by and between Aarvik Therapeutics, Inc. and the Registrant, as amended by Amendment No. 1, effective June 30, 2023 (ArriVent Biopharma, Inc., Filed With SEC on January 5, 2024)
- Joint Clinical Collaboration Agreement, by and between the Registrant and Shanghai Allist Pharmaceuticals Co., Ltd., dated December 24, 2021 (ArriVent Biopharma, Inc., Filed With SEC on January 5, 2024)
- First Amendment to the License and Collaboration Agreement, dated September 15, 2022, between Kissei Pharmaceutical Co., Ltd. and the Registrant (CG Oncology, Inc., Filed With SEC on January 2, 2024)
- License and Collaboration Agreement, dated March 26, 2020, between Kissei Pharmaceutical Co., Ltd. and the Registrant (CG Oncology, Inc., Filed With SEC on January 2, 2024)
- Collaboration and License Agreement dated November 8, 2013, between Orient Europharma Co., LTD. and NeOnc Technologies, Inc (NEONC TECHNOLOGIES HOLDINGS, INC., Filed With SEC on December 18, 2023)
- Collaboration Agreement, dated November 28, 2023, by and between the Company and Yuva BioSciences, Inc (Elevai Labs Inc., Filed With SEC on December 5, 2023)
- Third Amendment License and Collaboration Agreement by and between Zymeworks BC Inc. and BeiGene, Ltd., dated September 18, 2023 (Zymeworks Delaware Inc., Filed With SEC on September 21, 2023)
- Collaboration Agreement by and among the Registrant, Shopify Inc., Shopify International Limited, Shopify Commerce Singapore PTE. LTD., and Shopify Strategic Holdings 3 LLC, dated... (Klaviyo, Inc., Filed With SEC on August 25, 2023)
- License and Research Collaboration Agreement, dated August 4, 2020, by and between the Registrant and PeptiDream, Inc., as amended (RayzeBio, Inc., Filed With SEC on August 24, 2023)
- Research Collaboration and License Agreement, dated February 8, 2021, by and between the Registrant and Nimble Therapeutics, Inc., as amended (RayzeBio, Inc., Filed With SEC on August 24, 2023)
- Electronics Collaboration Agreement, dated July 2, 2023, by and between BorgWarner PDS (USA) Inc. and PHINIA Technologies Inc (PHINIA INC., Filed With SEC on July 7, 2023)
- Amended and Restated Master Collaboration Agreement, dated January 1, 2021, between Turnstone Biologics Corp. and H. Lee Moffitt Cancer Center and Research Institute, Inc (Turnstone Biologics Corp., Filed With SEC on June 12, 2023)
- Amended Collaboration & Engineering Services Agreement, dated as of May 24, 2023, by and between Textron Aviation Inc. and Surf Air Mobility Inc (SURF AIR MOBILITY INC., Filed With SEC on June 5, 2023)
- Collaboration& Engineering Services Agreement, dated as of September15, 2022, by and between Textron Aviation Inc. and Surf Air Mobility Inc (SURF AIR MOBILITY INC., Filed With SEC on June 5, 2023)
- Collaboration Agreement by and between JD E-commerce American Limited and Maison Solutions Inc. dated April 19, 2021 (English Translation) (Maison Solutions Inc., Filed With SEC on May 22, 2023)
- Amended and Restated License and Collaboration Agreement, dated May 15, 2023, by and between Zymeworks BC Inc. and Jazz Pharmaceuticals Ireland Limited (Zymeworks Delaware Inc., Filed With SEC on May 16, 2023)
- Collaboration and Revenue-Sharing Agreement between Signing Day Sports, Inc. and Louisville Slugger Hitting Science Center LLC, dated as of October 31, 2022 (Signing Day Sports, Inc., Filed With SEC on May 15, 2023)
- License and Collaboration Agreement by and between the Registrant and Affibody AB, dated August 9, 2021, as amended (ACELYRIN, Inc., Filed With SEC on April 13, 2023)
- LiDAR Product Collaboration Agreement between Mobileye Vision Technologies Ltd. and Intel Corporation, dated as of October 25, 2022 (Mobileye Global Inc., Filed With SEC on March 9, 2023)
- License and Collaboration Agreement, dated October 18, 2022, by and between Zymeworks BC Inc. and Jazz Pharmaceuticals Ireland Limited (Zymeworks Delaware Inc., Filed With SEC on March 7, 2023)
- License and Collaboration Agreement, dated April 9, 2020, by and between Innovative Health Solutions, Inc. and Masimo Corporation (Neuraxis, INC, Filed With SEC on January 10, 2023)
- Collaboration & Engineering Services Agreement, dated as of September 15, 2022, by and between Textron Aviation Inc. and Surf Air Mobility Inc (SURF AIR MOBILITY INC., Filed With SEC on October 24, 2022)
- Form of LiDAR Product Collaboration Agreement (Mobileye Global Inc., Filed With SEC on September 30, 2022)
- Collaboration and License Agreement, dated September 26, 2019, between Beam Therapeutics (Prime Medicine, Inc., Filed With SEC on September 23, 2022)
- Research and Development Collaboration Agreement, dated as of December 14, 2021, by and between TeleSign and Proximus (NAAC Holdco, Inc., Filed With SEC on March 21, 2022)
- Collaboration Agreement, dated January 29, 2021, by and between Duke Airborne Systems Ltd. and Elbit Systems Land Ltd. (translation from Hebrew) (UAS Drone Corp., Filed With SEC on March 30, 2021)
- Collaboration Agreement effective March 18, 2020 with Aingura IIoT, S.L (IIOT-OXYS, Inc., Filed With SEC on August 19, 2020)
- Research Collaboration Agreement between Nascent Biotech Inc. and Manhattan BioSolutions, Inc. dated April 30, 2020 (Nascent Biotech Inc., Filed With SEC on May 14, 2020)
- COLLABORATION AGREEMENT (Phoenix Plus Corp., Filed With SEC on December 20, 2019)
- COLLABORATION AGREEMENT (Phoenix Plus Corp., Filed With SEC on December 2, 2019)
- Blockchain Software Development and Collaboration Agreement dated June 6, 2018 with Bengala Technologies, LLC (International Spirits & Beverage Group, Inc., Filed With SEC on September 26, 2018)
- COLLABORATION AGREEMENT by and between ROKK3R INC., and ROKK3R LABS, LLC. (Rokk3r Inc., Filed With SEC on April 17, 2018)
- Sixth Amendment to Collaboration Agreement, by and among the Company, F. Hoffmann-La Roche Ltd and Hoffman-La Roche Inc., dated November 1, 2017 (Foundation Medicine, Inc., Filed With SEC on March 7, 2018)
- Amendment No. 1 to Collaboration, Development and License Agreement, dated February 26, 2018, by and between the Company and Zai Lab (Shanghai) Co., Ltd (TESARO, Inc., Filed With SEC on February 28, 2018)
- Revised Collaboration Agreement by and among MSNI (M) Sdn Bhd and Monspacemall Bhd dated November 8, 2017 (MON SPACE NET INC., Filed With SEC on November 13, 2017)
- Fifth Amendment to Collaboration Agreement, by and among the Company, F. Hoffmann-La Roche Ltd and Hoffman-La Roche Inc., dated September 8, 2017 (Foundation Medicine, Inc., Filed With SEC on September 13, 2017)
